Myriad: Fourth Quarter Financial Highlights

Myriad Genetics Reports Fourth Quarter Financial Results

Myriad Genetics Inc., headquartered in Salt Lake City, announced on Monday that it recorded a net loss of $7.9 million for its fourth fiscal quarter.

The company reported a loss of $0.08 per share. After adjusting for expenses related to mergers, acquisitions, and asset impairments, adjusted earnings stood at $0.04 per share.

These adjusted results exceeded analysts’ expectations. According to a survey of five analysts by Zacks Investment Research, the consensus forecast was a loss of $0.02 per share.

During the quarter, Myriad Genetics generated $209.8 million in revenue.

For the full fiscal year, the company posted a total loss of $365.9 million, or $3.95 per share, with annual revenue reaching $824.5 million.

Looking ahead, Myriad Genetics anticipates its revenue for the upcoming year will fall between $860 million and $880 million.

Financial data for this article was sourced from Zacks Investment Research and compiled by Automated Insights.